Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under Vitamin K antagonists

  1. Ríos, S.J.
  2. Rivera-Caravaca, J.M.
  3. Aroca-Valverde, C.
  4. Reguilón-Gallego, L.
  5. Castillo-Rodríguez, M.
  6. Esteve-Pastor, M.A.
  7. Vicente, V.
  8. Marín, F.
  9. Roldán, V.
Aldizkaria:
QJM

ISSN: 1460-2393,  1460-2725

Argitalpen urtea: 2019

Alea: 112

Zenbakia: 3

Orrialdeak: 183-188

Mota: Artikulua

DOI: 10.1093/QJMED/HCY250 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus